Christian Blank obtained his MD from the Medical School of the Technical University Munich, Germany, where he also completed his Doctoral thesis (summa cum laude) at the Department for Medical Microbiology in 1997. As a Junior House Officer (1997–1998) he held four positions at the Departments of Cardiology and of Radiology at the University Clinic Munich Rechts der Isar, Munich, the Accident and Emergency (A&E) Departments at the Royal Infirmary of Edinburgh, and the University of Birmingham, UK. He went on to attain the position of Physician at the Department of Haematology and Oncology, University of Regensburg, Germany (1998–2001). During 2001–2003, Dr Blank held a Postdoctoral Research Fellowship at the lab of Professor Thomas Gajewski, University of Chicago, IL, USA. Subsequently he was appointed as Physician and Research Group Leader at the Department of Haematology and Oncology, University of Regensburg (2003–2007). Dr Blank has obtained two Specialist Degrees in Internal Medicine (2007) and in Haematology/Oncology (2009). Since 2007, he has been appointed Staff Member at the Department of Medical Oncology, and Group Leader at the Division of Immunology, NKI-AVL, Amsterdam. In 2010, Dr Blank became University Lecturer (Privatdozent) at the University of Regensburg. He obtained his Master of Business Administration (MBA), from the University of Warwick, UK (2006). Dr Blank is committed to teaching, lecturing on medical courses at the NKI-AVL and the Medical School of the University of Regensburg. He is a member of four prestigious societies, including ESMO and ASCO. He has been an invited speaker at more than 80 national and international congresses, and is the author of more than 60 publications. His research interests broadly include targeted and biological response modifiers, and prognostic markers in melanoma and RCC.

Manuel Cobo Dols, Md, Phd is a medical oncologist at the Hospital Regional Universitario Málaga and IBIMA (Málaga, Spain). He is Licenciated in Medicine and Surgery from the University of Malaga, a Doctor of Medicine and Surgery in the Chair of Normal and Pathological Anatomy and an Internal Medical Resident of Medical Oncology at Carlos Haya Regional Hospital (period 1995-1998). He is also Chairman in the Medical Oncology Service at the University Regional Hospital, Málaga.
Dr Cobo Dols has an active participation in more than 90 research lines and national and international clinical trials in the lines of research carried out by the Medical Oncology Service of the Regional University Hospital Málaga (period 1995-2018). He has authored 55 publications in national journals and 45 publications in international journals of high impact, including Journal of Clinical Oncology, Lancet, JAMA, Lancer Oncology, Clinical Cancer Research, Annals of Oncology among others. He has more than 80 papers in national and international conferences and scientific meetings, as well as over 200 communications in national and international meetings. Dr Cobo Dols is a member of several societies, namely the Spanish Society of Medical Oncology (SEOM), Andalusian Society of Medical Oncology (SAC), International Society of Lung Cancer (IASL) and the Spanish Lung Cancer Group (GECP).

Jocelyne Demengeot scientific interests relate to the development and function of lymphocytes, with a particular focus on immune tolerance to organ and tissues, in health and disease. Her research team is most known for its contribution to the understanding of regulatory T cells origin and dynamics.Their approaches are based on the exploration of mouse models as well as collaborations with clinicians and further afield scientists. Jocelyne Demengeot acquired her PhD in Marseille, France, and post-doctoral training in Columbia U NY and Harvard Medical school Boston. She joined the Instituto Gulbenkian de Ciência at its 1998 reform, where she also assumed various managerial responsibilities. She endorsed one term of presidency of the Portuguese society of Immunology.

http://www.igc.gulbenkian.pt/jdemengeot